Phosphoenolpyruvate carboxykinase

Not to be confused with Phosphoenolpyruvate carboxylase.

Phosphoenolpyruvate carboxykinase
PDB rendering based on 1khb.
Identifiers
Symbol	PEPCK
Pfam	PF00821
InterPro	IPR008209
PROSITE	PDOC00421
SCOP	1khf
Available protein structures: Pfam structures PDB RCSB PDB; PDBe PDBsum structure summary

phosphoenolpyruvate carboxykinase 1 (soluble)
Identifiers
Symbol	PCK1
Alt. symbols	PEPCK-C
Entrez	5105
HUGO	8724
OMIM	261680
RefSeq	NM_002591
Other data
EC number	4.1.1.32
Locus	Chr. 20 q13.31

phosphoenolpyruvate carboxykinase 2 (mitochondrial)
Identifiers
Symbol	PCK2
Alt. symbols	PEPCK, PEPCK2
Entrez	5106
HUGO	8725
OMIM	261650
RefSeq	NM_001018073
Other data
EC number	4.1.1.32
Locus	Chr. 14 q12

Phosphoenolpyruvate carboxykinase (PEPCK) is an enzyme in the lyase family used in the metabolic pathway of gluconeogenesis. It converts oxaloacetate into phosphoenolpyruvate and carbon dioxide.

It is found in two forms, cytosolic and mitochondrial.

Reversibility

Whereas most reactions of gluconeogenesis can use the glycolysis enzymes in the opposite direction, the pyruvate kinase enzyme is irreversible. The enzymes pyruvate carboxylase and phosphoenolpyruvate carboxykinase provide an alternate path to effectively reverse the actions of pyruvate kinase.

PEPCK in different species

PEPCK gene transcription (genetics) occurs in many species, and the amino acid sequence of PEPCK is distinct for each species.

For example, its structure and its specificity differ in humans, Escherichia coli (E. coli), and the parasiteTrypanosoma cruzi.^[1]

Animals

In animals, this is a rate-controlling step of gluconeogenesis, the process by which cells synthesize glucose from metabolic precursors. The blood glucose level is maintained within well-defined limits in part due to precise regulation of PEPCK gene expression. To emphasize the importance of PEPCK in glucose homeostasis, over expression of this enzyme in mice results in symptoms of type II diabetes mellitus, by far the most common form of diabetes in humans. Due to the importance of blood glucose homeostasis, a number of hormones regulate a set of genes (including PEPCK) in the liver that modulate the rate of glucose synthesis.

PEPCK is controlled by two different hormonal mechanisms. PEPCK activity is increased upon the secretion of both cortisol from the adrenal cortex and glucagon from the alpha cells of the pancreas. Glucagon indirectly elevates the expression of PEPCK by increasing the levels of cAMP (via activation of adenylyl cyclase) in the liver which consequently phosphorylates the S133 on a beta sheet in the CREB protein. CREB then binds upstream of the PEPCK gene at CRE (cAMP response element) and induces PEPCK transcription. Cortisol on the other hand, when released by the adrenal cortex, passes through the lipid membrane of liver cells (due to its hydrophobic nature it can pass directly through cell membranes) and then binds to a Glucocorticoid Receptor (GR). This receptor dimerizes and the cortisol/GR complex passes into the nucleus where it then binds to the Glucocorticoid Response Element (GRE) region in a similar manner to CREB and produces similar results (synthesis of more PEPCK).

Together, Cortisol and Glucagon can have huge synergistic results. Activating the PEPCK gene to levels that neither cortisol or glucagon could reach on their own.It is most abundant in the liver, kidney, and adipose tissue.^[2]

Researchers at Case Western Reserve University have discovered that overexpression of cytosolic PEPCK in skeletal muscle of mice causes them to be more active, more aggressive, and have longer lives than normal mice; see metabolic supermice.

Plants

In plant C4 carbon fixation, carbon dioxide is first fixed by combination with phosphoenolpyruvate to form oxaloacetate in the mesophyll. In PEPCK-type C4 plants the oxaloacetate is then converted to aspartate, which travels to the bundle sheath. In the bundle sheath cells, aspartate is converted back to oxaloacetate. PEPCK decarboxylates the bundle sheath oxaloacetate, releasing carbon dioxide, which is then fixed by the enzyme Rubisco.

PEPCK acts in plants that undergo C4 carbon fixation, where its action has been localized to the cytosol, in contrast to mammals, where it has been found that PEPCK works in mitochondria.^[3]

Although it is found in many different parts of plants, it has been seen only in specific cell types, including the areas of the phloem.^[4]

It has also been discovered that, in cucumber (Cucumis sativus L.), PEPCK levels are increased by multiple effects that are known to decrease the cellular pH of plants, although these effects are specific to the part of the plant.^[4]

PEPCK levels rose in roots and stems when the plants were watered with ammonium chloride at a low pH (but not at high pH), or with butyric acid. However, PEPCK levels did not increase in leaves under these conditions.

In leaves, 5% CO2 content in the atmosphere leads to higher PEPCK abundance.^[4]

Bacteria

In an effort to explore the role of PEPCK, researchers caused the overexpression of PEPCK in E. coli bacteria via recombinant DNA.^[5]

Function in gluconeogenesis

It has been shown that PEPCK catalyzes the rate-controlling step of gluconeogenesis, the process whereby glucose is synthesized. The enzyme has therefore been thought to be essential in glucose homeostasis, as evidenced by laboratory mice that contracted diabetes mellitus type 2 as a result of the overexpression of PEPCK.^[6]

A recent study suggests that the role that PEPCK plays in gluconeogenesis may be mediated by the citric acid cycle, the activity of which was found to be directly related to PEPCK abundance.^[7]

PEPCK levels alone were not found to be highly correlated with gluconeogenesis in the mouse liver, as previous studies have suggested.^[7] Therefore, the role of PEPCK in gluconeogenesis may be more complex and involve more factors than was previously believed.

PEPCK of Mycobacterium tuberculosis has been shown to trigger the immune system in mice by increasing cytokine activity.^[8]

As a result, it has been found that PEPCK may be an appropriate ingredient in the development of an effective subunit vaccination for tuberculosis.^[8]

Structure

In humans there are two isoforms of PEPCK; a cytosolic form (SwissProt P35558) and a mitochondrial isoform (SwissProt Q16822) which have 63.4% sequence identity. The cytosolic form is important in gluconeogenesis. However, there is a known transport mechanism to move PEP from the mitochondria to the cytosol, using specific membrane transport proteins.

X-ray structures of PEPCK provide insight into the structure and the mechanism of PEPCK enzymatic activity. The mitochondrial isoform of chicken liver PEPCK complexed with Mn²⁺, Mn2+-phosphoenolpyruvate (PEP), and Mn²⁺-GDP provides information about its structure and how this enzyme catalyzes reactions.^[9] Delbaere et al. (2004) resolved PEPCK in E. coli and found the active site sitting between a C-terminal domain and an N-terminal domain. The active site was observed to be closed upon rotation of these domains.^[10]

Phosphoryl groups are transferred during PEPCK action, which is likely facilitated by the eclipsed conformation of the phosphoryl groups when ATP is bound to PEPCK.^[10]

Since the eclipsed formation is one that is high in energy, phosphoryl group transfer has a decreased energy of activation, meaning that the groups will transfer more readily. This transfer likely happens via a mechanism similar to SN2 displacement.^[10]

Reaction Pathway

PEPCase converts oxaloacetate into phosphoenolpyruvate and carbon dioxide.

• 

  oxaloacetate

• 

  phosphoenolpyruvate

As PEPCK acts at the junction between glycolysis and the Krebs cycle, it causes decarboxylation of a C4 molecule, creating a C3 molecule. As the first committed step in gluconeogenesis, PEPCK decarboxylates, and phosphorylates oxaloacetate (OAA) for its conversion to PEP, when GTP is present. As a phosphate is transferred, the reaction results in a GDP molecule.^[9] It is interesting to note that, when pyruvate kinase - the enzyme that normally catalyzes the reaction that converts PEP to pyruvate - is knocked out in mutants of Bacillus subtilis, PEPCK participates in one of the replacement anaplerotic reactions, working in the reverse direction of its normal function, converting PEP to OAA.^[11] Although this reaction is possible, the kinetics are so unfavorable that the mutants grow at a very slow pace or do not grow at all.^[11]

In fermentation, PEPCK catalyzes the reaction of PEP and carbon dioxide to OAA and ADP is therefore converted to ATP with the addition of a phosphate group.^[12]

Regulation

In humans

PEPCK is enhanced, both in terms of its production and activation, by many factors. Transcription of the PEPCK gene is stimulated by glucagon, glucocorticoids, retinoic acid, and adenosine 3’,5’-monophosphate (cAMP), while it is inhibited by insulin.^[13] Of these factors, insulin, a hormone that is deficient in the case of diabetes, is considered dominant, as it inhibits the transcription of many of the stimulatory elements.^[13] PEPCK activity is also inhibited by hydrazine sulfate, and the inhibition therefore decreases the rate of gluconeogenesis.^[14]

In prolonged acidosis, PEPCK is upregulated in renal proximal tubule brush border cells, in order to secrete more NH₃ and thus to produce more HCO₃^-.^[15]

The GTP-specific activity of PEPCK is highest when Mn2+ and Mg2+ are available.^[5] In addition, hyper-reactive cysteine (C307) is involved in the binding of Mn2+ to the active site.^[9]

Plants

As discussed previously, PEPCK abundance increased when plants were watered with low-pH ammonium chloride, though high pH did not have this effect.^[4]

Classification

It is classified under EC number 4.1.1. There are three main types, distinguished by the source of the energy to drive the reaction:

• 4.1.1.32 - GTP (PCK1, PCK2)
• 4.1.1.38 - diphosphate
• 4.1.1.49 - ATP

References

1. ^ Trapani S, Linss J, Goldenberg S, Fischer H, Craievich AF, Oliva G (November 2001). "Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution". Journal of molecular biology 313 (5): 1059–72. doi:10.1006/jmbi.2001.5093. PMID 11700062. 
2. ^ Chakravarty K, Cassuto H, Reshef L, Hanson RW (2005). "Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C". Critical reviews in biochemistry and molecular biology 40 (3): 129–54. doi:10.1080/10409230590935479. PMID 15917397. 
3. ^ Voznesenskaya, E.V., Franceschi, V.R., Chuong, S.D., & Edwards, G.E. (2006) Functional characterization of phosphoenolpyruvate carboxykinase-type C4 leaf anatomy: immuno-cytochemical and ultrastructural analyses. Annals of Botany, 98(1), 77-91.
4. ^ ^{a b c d} Chen ZH, Walker RP, Técsi LI, Lea PJ, Leegood RC (May 2004). "Phosphoenolpyruvate carboxykinase in cucumber plants is increased both by ammonium and by acidification, and is present in the phloem". Planta 219 (1): 48–58. doi:10.1007/s00425-004-1220-y. PMID 14991407. 
5. ^ ^{a b} Aich S, Imabayashi F, Delbaere LT (October 2003). "Expression, purification, and characterization of a bacterial GTP-dependent PEP carboxykinase". Protein expression and purification 31 (2): 298–304. doi:10.1016/S1046-5928(03)00189-X. PMID 14550651. 
6. ^ Vanderbilt Medical Center. “Granner Lab, PEPCK Research.” 2001. Online. Internet. Accessed 10:46PM, 4/13/07. www.mc.vanderbilt.edu/root/vumc.php?site=granner&doc=119
7. ^ ^{a b} Burgess SC, He T, Yan Z, Lindner J, Sherry AD, Malloy CR, Browning JD, Magnuson MA (April 2007). "Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver". Cell metabolism 5 (4): 313–20. doi:10.1016/j.cmet.2007.03.004. PMC 2680089. PMID 17403375. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2680089. 
8. ^ ^{a b} Liu K, Ba X, Yu J, Li J, Wei Q, Han G, Li G, Cui Y. (August 2006). "The phosphoenolpyruvate carboxykinase of Mycobacterium tuberculosis induces strong cell-mediated immune responses in mice". Molecular and cellular biochemistry 288 (1-2): 65–71. doi:10.1007/s11010-006-9119-5. PMID 16691317. 
9. ^ ^{a b c} Holyoak T, Sullivan SM, Nowak T (July 2006). "Structural insights into the mechanism of PEPCK catalysis". Biochemistry 45 (27): 8254–63. doi:10.1021/bi060269g. PMID 16819824. 
10. ^ ^{a b c} Delbaere LT, Sudom AM, Prasad L, Leduc Y, Goldie H (March 2004). "Structure/function studies of phosphoryl transfer by phosphoenolpyruvate carboxykinase". Biochimica et Biophysica Acta 1697 (1-2): 271–8. doi:10.1016/j.bbapap.2003.11.030. PMID 15023367. 
11. ^ ^{a b} Zamboni N, Maaheimo H, Szyperski T, Hohmann HP, Sauer U (October 2004). "The phosphoenolpyruvate carboxykinase also catalyzes C3 carboxylation at the interface of glycolysis and the TCA cycle of Bacillus subtilis". Metabolic engineering 6 (4): 277–84. doi:10.1016/j.ymben.2004.03.001. PMID 15491857. 
12. ^ Chao YP, Liao JC (February 1994). "Metabolic responses to substrate futile cycling in Escherichia coli". The Journal of biological chemistry 269 (7): 5122–6. PMID 8106492. http://www.jbc.org/cgi/reprint/269/7/5122. 
13. ^ ^{a b} O'Brien RM, Lucas PC, Forest CD, Magnuson MA, Granner DK (August 1990). "Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription". Science 249 (4968): 533–7. doi:10.1126/science.2166335. PMID 2166335. 
14. ^ Mazzio E, Soliman KF (January 2003). "The role of glycolysis and gluconeogenesis in the cytoprotection of neuroblastoma cells against 1-methyl 4-phenylpyridinium ion toxicity". Neurotoxicology 24 (1): 137–47. doi:10.1016/S0161-813X(02)00110-9. PMID 12564389. 
15. ^ Walter F., PhD. Boron. Medical Physiology: A Cellular And Molecular Approaoch. Elsevier/Saunders. ISBN 1-4160-2328-3.  Page 858

External links

• MeSH Phosphoenolpyruvate+Carboxykinase+(ATP)
• MeSH Phosphoenolpyruvate+Carboxykinase+(GTP)
• -872021957 at GPnotebook
• "mighty mice" (PEPCK-Cmus mice) http://blog.case.edu/case-news/2007/11/02/mightymouse